Stromal cell PD-L1iInhibits CD8(+) T-cell antitumor immune responses and promotes colon cancer
O'Malley, Grace Treacy, Oliver Lynch, Kevin Naicker, Serika D. Leonard, Niamh A. Lohan, Paul Dunne, Philip D. Ritter, Thomas Egan, Laurence J. Ryan, Aideen E.
O'Malley, Grace
Treacy, Oliver
Lynch, Kevin
Naicker, Serika D.
Leonard, Niamh A.
Lohan, Paul
Dunne, Philip D.
Ritter, Thomas
Egan, Laurence J.
Ryan, Aideen E.
Loading...
Publication Date
2018-11
Type
Article
Downloads
Citation
O'Malley, Grace, Treacy, Oliver, Lynch, Kevin, Naicker, Serika D., Leonard, Niamh A., Lohan, Paul, Dunne, Philip D., Ritter, Thomas, Egan, Laurence J., Ryan, Aideen E. (2018). Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer. Cancer Immunology Research, 6(11), 1426-1441. doi: 10.1158/2326-6066.cir-17-0443
Abstract
Stromal cells of mesenchymal origin reside below the epithelial compartment and provide structural support in the intestine. These intestinal stromal cells interact with both the epithelial cell compartments, as well as infiltrating hematopoietic immune cells. The importance of these cells in regulating immune homeostasis during inflammation is well recognized. However, little is known about their function and phenotype in the inflammatory tumor microenvironment. Using a syngeneic, immunogenic model of colorectal cancer, we showed that TNFa-initiated inflammatory signaling in CT26 colorectal cancer cells selectively induced PD-L1 expression in stromal cells. Using CD274 shRNA and antibodymediated approaches, we showed that stromal cell PD-L1 potentiated enhanced immunosuppression, characterized by inhibition of activated CD8(+) granzyme B-secreting T cells in vitro, and the inhibition of CD8(+) effector cells was associated with enhanced tumor progression. Stromal cell immunosuppressive and tumor-promoting effects could be reversed with administration of anti-PD-1 in vivo. We validated our findings of stromal cell CD274 expression in two cohorts of clinical samples and also observed PD-L1 induction on human stromal cells in response to exposure to the inflammatory secretome fromhuman colon cancer cells, irrespective of microsatellite instability. Collectively, our data showed that tumor-associated stromal cells support T-cell suppression by PD-L1 induction, which is dependent on colon cancer inflammatory signaling. Our findings reveal a key role of mesenchymal stromal cells PD-L1 in suppression of CD8(+) antitumor immune responses and potentiation of colorectal cancer progression. (C) 2018 AACR.
Publisher
American Association for Cancer Research
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland